Bolt Biotherapeutics, Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
- 3 insiders sold shares within a monthSince Sep 18, 2026+5.7
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
9 sales (9 not pre-planned) · 2 purchases
- Yonehiro GrantChief Operating Officer · Sep 18, 2026Sold 6,850 sharesabout $22 thousand · not pre-planned
- Nemec SarahSenior VP, Finance and PAO · Sep 18, 2026Sold 4,077 sharesabout $13 thousand · not pre-planned
- Quinn William P.President, CEO and CFO · Sep 18, 2026Sold 9,132 sharesabout $30 thousand · not pre-planned
- Yonehiro GrantChief Operating Officer · Sep 17, 2026Sold 4,909 sharesabout $16 thousand · not pre-planned
- Nemec SarahSenior VP, Finance and PAO · Sep 17, 2026Sold 2,922 sharesabout $10 thousand · not pre-planned
- Quinn William P.President, CEO and CFO · Sep 17, 2026Sold 6,545 sharesabout $22 thousand · not pre-planned
- Yonehiro GrantChief Operating Officer · Sep 16, 2026Sold 1,417 sharesabout $5 thousand · not pre-planned
- Nemec SarahSenior VP, Finance and PAO · Sep 16, 2026Sold 843 sharesabout $3 thousand · not pre-planned
- Quinn William P.President, CEO and CFO · Sep 16, 2026Sold 1,889 sharesabout $7 thousand · not pre-planned
- Nemec SarahSenior VP, Finance and PAO · Jun 5, 2026Bought 509 sharesabout $2 thousand ·
- Quinn William P.President, CEO and CFO · Jun 5, 2026Bought 637 sharesabout $2 thousand ·
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
- Signed a major agreement; Ended a major agreement; An executive or board member joined or left; Shared information with investors; Other newsNews report (8-K)Oct 23, 2026
- Signed a major agreementNews report (8-K)Oct 6, 2026
- Quarterly reportQuarterly report (10-Q)Aug 11, 2026
- Shared quarterly resultsNews report (8-K)Aug 11, 2026
- News reportNews report (8-K)Jun 11, 2026
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.